This research examined the impact of in-vehicle information system (IVIS) interactions on the driver's cognitive workload; 257 subjects participated in a weeklong evaluation of the IVIS interaction in one of ten different model-year 2015 automobiles. After an initial assessment of the cognitive workload associated with using the IVIS, participants took the vehicle home for 5 days and practiced using the system. At the end of the 5 days of practice, participants returned and the workload of these IVIS interactions was reassessed. The cognitive workload was found to be moderate to high, averaging 3.34 on a 5-point scale and ranged from 2.37 to 4.57. The workload was associated with the intuitiveness and complexity of the system and the time it took participants to complete the interaction. The workload experienced by older drivers was significantly greater than that experienced by younger drivers performing the same operations. Practice did not eliminate the interference from IVIS interactions. In fact, IVIS interactions that were difficult on the first day were still relatively difficult to perform after a week of practice. Finally, there were long-lasting residual costs after the IVIS interactions had terminated. The higher levels of workload should serve as a caution that these voice-based interactions can be cognitively demanding and ought not to be used indiscriminately while operating a motor vehicle.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256443 | PMC |
http://dx.doi.org/10.1186/s41235-016-0018-3 | DOI Listing |
Int Immunopharmacol
January 2025
Department of Scientific Research, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, China. Electronic address:
Bioconjug Chem
January 2025
Canary Center for Cancer Early Detection, Department of Radiology, Stanford University, Palo Alto, California 94304, United States.
The interaction between cancer cells and immune cells in the tumor microenvironment (TME) plays a crucial role in determining tumor growth, metastasis, and response to treatment. Tumor-infiltrating lymphocytes (TILs) in TME could be a predictive marker for treatment response in various therapeutic interventions, including chemotherapy and immunotherapy. Thus, imaging the tumor immune microenvironment is important for selecting the optimal treatment strategies in cancer therapy.
View Article and Find Full Text PDFSci Rep
August 2024
Department of Industrial Design, School of Design, Southwest Jiaotong University, Chengdu, 611756, China.
Biosens Bioelectron
November 2024
Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu, 300, Taiwan; Center for Intelligent Drug Systems and Smart Bio-devices (IDS(2)B), National Yang Ming Chiao Tung University, Hsinchu, 300, Taiwan. Electronic address:
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is facilitated by its trimeric surface spike protein, which binds to the human angiotensin-converting enzyme 2 (hACE2) receptor. This critical interaction facilitates viral entry and is a primary target for therapeutic intervention against COVID-19. However, it is difficult to fully optimize viral infection using existing protein-protein interaction methods.
View Article and Find Full Text PDFACS Nano
June 2024
School of Biological and Food Engineering, Anhui Polytechnic University, Wuhu, Anhui 241000, Peoples Republic of China.
The active targeting drug delivery system based on special types of endogenous cells such as macrophages has emerged as a promising strategy for tumor therapy, owing to its tumor homing property and biocompatibility. In this work, the active tumor-targeting drug delivery system carrying doxorubicin-loaded nanoparticles (DOX@MPF127-MCP-1, DMPM) on macrophage (RAW264.7) surfaces via the mediation of interaction with the CCR2/MCP-1 axis was exploited.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!